Safety and Efficacy of Anlotinib With Chemoradiation for Patients With Locally Advanced Nasopharyngeal Carcinoma: a Phase 2 Study
Latest Information Update: 20 Jul 2022
At a glance
- Drugs Catequentinib (Primary) ; Cisplatin (Primary) ; Docetaxel (Primary)
- Indications Carcinoma; Nasopharyngeal cancer
- Focus Therapeutic Use
Most Recent Events
- 07 Jun 2022 Results (Cut off : January 24, 2022, N=34) presented at the 58th Annual Meeting of the American Society of Clinical Oncology
- 14 Feb 2022 New trial record